ResMed Inc (ASX: RMD) is a United States based business that develops and manufactures medical devices to help people with sleep apnea, chronic obstructive pulmonary disease (COPD) and other chronic diseases. ResMed, which is short for Respiratory Medicine, was founded in 1989 by Dr Peter Farrell and now helps customers & patients in over 120 countries.
Here are the headlines from the S&P/ASX 200 (INDEXASX:XJO)(ASX:XJO) and Australian finance circles on Thursday morning.
SomnoMed Limited (ASX:SOM) today reported it achieved 30% revenue growth in its 2018 financial year.
The Aussie sharemarket or ALL ORDINARIES (INDEXASX:XAO)(ASX:XAO) index closed higher on Monday as ResMed Inc. (CHESS) (ASX:RMD) shares push upwards.
Australia’s share market, or the All Ordinaries (INDEXASX: XAO)(ASX: XAO), has opened in the green by 0.40%.
Australia’s share market, or the All Ordinaries (INDEXASX: XAO)(ASX: XAO), has opened positively in the green by 0.28%.
Australia’s ALL ORDINARIES (INDEXASX:XAO)(ASX:XAO) index closed higher on Tuesday, lifted by ResMed Inc. (CHESS) (ASX:RMD) shares.
Australia’s share market, or the All Ordinaries (INDEXASX: XAO)(ASX: XAO), has opened positively in the green by 0.63%.
Shares of the leading Australian biotechnology company ResMed Inc. (CHESS) (ASX:RMD) bounced 8% on Tuesday following a bumper quarterly report.
